Japan In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Table Of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
2.2 In Vitro Diagnostics Market Segmentation 14
2.3 Definitions of Markets Covered in the Report 17
3 In Vitro Diagnostics Market, Japan 30
3.1 In Vitro Diagnostics Market, Japan, Revenue ($m), 2007-2021 30
3.2 In Vitro Diagnostics Market, Japan, Revenue Mix ($m), 2014 32
3.3 In Vitro Diagnostics Market, Japan, Category Contribution by Revenue ($m), 2014 33
3.4 In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), 2007-2021 34
3.5 In Vitro Diagnostics Market, Japan, Revenue ($m), 2007-2014 36
3.6 In Vitro Diagnostics Market, Japan, Revenue ($m), 2014-2021 38
3.7 In Vitro Diagnostics Market, Japan, Company Share by Revenue ($m), 2014 40
4 Clinical Chemistry Market, Japan 42
4.1 Clinical Chemistry Market, Japan, Revenue Mix ($m), 2014 42
4.2 Clinical Chemistry Market, Japan, Segment Contribution (%), 2014 43
4.3 Clinical Chemistry Market, Japan, Revenue ($m), 2007-2014 45
4.4 Clinical Chemistry Market, Japan, Revenue ($m), 2014-2021 47
4.4.1 Clinical Chemistry Analyzers Market, Japan, Revenue ($m), by Segment, 2007-2014 49
4.4.2 Therapeutic Drug Monitoring Market, Japan, Revenue ($m), by Segment, 2007-2014 51
4.4.3 Urine Analysis Market, Japan, Revenue ($m), by Segment, 2007-2014 53
4.4.4 Clinical Chemistry Analyzers Market, Japan, Revenue ($m), by Segment, 2014-2021 55
4.4.5 Therapeutic Drug Monitoring Market, Japan, Revenue ($m), by Segment, 2014-2021 57
4.4.6 Urine Analysis Market, Japan, Revenue ($m), by Segment, 2014-2021 59
4.5 Clinical Chemistry Market, Japan, Distribution Share by Revenue ($m), 2013-2014 61
4.6 Clinical Chemistry Market, Japan, Company Share by Revenue ($m), 2014 62
5 Genetic Testing Market, Japan 64
5.1 Genetic Testing Market, Japan, Revenue Mix ($m), 2014 64
5.2 Genetic Testing Market, Japan, Segment Contribution (%), 2014 65
5.3 Genetic Testing Market, Japan, Revenue ($m), 2007-2014 66
5.4 Genetic Testing Market, Japan, Revenue ($m), 2014-2021 68
5.5 Genetic Testing Market, Japan, Distribution Share by Revenue ($m), 2013-2014 70
5.6 Genetic Testing Market, Japan, Company Share by Revenue ($m), 2014 71
6 Haematology Market, Japan 73
6.1 Haematology Market, Japan, Revenue Mix ($m), 2014 73
6.2 Haematology Market, Japan, Segment Contribution (%), 2014 74
6.3 Haematology Market, Japan, Revenue ($m), 2007-2014 76
6.4 Haematology Market, Japan, Revenue ($m), 2014-2021 78
6.4.1 Haematology Cell Counters Market, Japan, Revenue ($m), by Segment, 2007-2014 80
6.4.2 Haematology Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2007-2014 82
6.4.3 Haematology Reagents Market, Japan, Revenue ($m), by Segment, 2007-2014 84
6.4.4 Haemostasis Market, Japan, Revenue ($m), by Segment, 2007-2014 86
6.4.5 Immunohaematology Market, Japan, Revenue ($m), by Segment, 2007-2014 88
6.4.6 Haematology Cell Counters Market, Japan, Revenue ($m), by Segment, 2014-2021 90
6.4.7 Haematology Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2014-2021 92
6.4.8 Haematology Reagents Market, Japan, Revenue ($m), by Segment, 2014-2021 94
6.4.9 Haemostasis Market, Japan, Revenue ($m), by Segment, 2014-2021 96
6.4.10 Immunohaematology Market, Japan, Revenue ($m), by Segment, 2014-2021 98
6.5 Haematology Market, Japan, Distribution Share by Revenue ($m), 2013-2014 100
6.6 Haematology Market, Japan, Company Share by Revenue ($m), 2014 101
7 Histology And Cytology Market, Japan 103
7.1 Histology And Cytology Market, Japan, Revenue Mix ($m), 2014 103
7.2 Histology And Cytology Market, Japan, Segment Contribution (%), 2014 104
7.3 Histology And Cytology Market, Japan, Revenue ($m), 2007-2014 106
7.4 Histology And Cytology Market, Japan, Revenue ($m), 2014-2021 108
7.5 Histology And Cytology Market, Japan, Distribution Share by Revenue ($m), 2013-2014 110
7.6 Histology And Cytology Market, Japan, Company Share by Revenue ($m), 2014 111
8 Immuno Chemistry Market, Japan 113
8.1 Immuno Chemistry Market, Japan, Revenue Mix ($m), 2014 113
8.2 Immuno Chemistry Market, Japan, Segment Contribution (%), 2014 114
8.3 Immuno Chemistry Market, Japan, Revenue ($m), 2007-2014 116
8.4 Immuno Chemistry Market, Japan, Revenue ($m), 2014-2021 118
8.4.1 Anemia Tests Market, Japan, Revenue ($m), by Segment, 2007-2014 120
8.4.2 Disease Specific Immunochemistry Market, Japan, Revenue ($m), by Segment, 2007-2014 122
8.4.3 Endocrinology Tests Market, Japan, Revenue ($m), by Segment, 2007-2014 124
8.4.4 IgE Allergy Blood Tests Market, Japan, Revenue ($m), by Segment, 2007-2014 126
8.4.5 Immunochemistry Analyzers Market, Japan, Revenue ($m), by Segment, 2007-2014 128
8.4.6 Immunochemistry Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2007-2014 130
8.4.7 Vitamins Tests Market, Japan, Revenue ($m), by Segment, 2007-2014 132
8.4.8 Anemia Tests Market, Japan, Revenue ($m), by Segment, 2014-2021 134
8.4.9 Disease Specific Immunochemistry Market, Japan, Revenue ($m), by Segment, 2014-2021 136
8.4.10 Endocrinology Tests Market, Japan, Revenue ($m), by Segment, 2014-2021 138
8.4.11 IgE Allergy Blood Tests Market, Japan, Revenue ($m), by Segment, 2014-2021 140
8.4.12 Immunochemistry Analyzers Market, Japan, Revenue ($m), by Segment, 2014-2021 142
8.4.13 Immunochemistry Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2014-2021 144
8.4.14 Vitamins Tests Market, Japan, Revenue ($m), by Segment, 2014-2021 146
8.5 Immuno Chemistry Market, Japan, Distribution Share by Revenue ($m), 2013-2014 148
8.6 Immuno Chemistry Market, Japan, Company Share by Revenue ($m), 2014 149
9 Infectious Diagnostics Market, Japan 151
9.1 Infectious Diagnostics Market, Japan, Revenue Mix ($m), 2014 151
9.2 Infectious Diagnostics Market, Japan, Segment Contribution (%), 2014 152
9.3 Infectious Diagnostics Market, Japan, Revenue ($m), 2007-2014 154
9.4 Infectious Diagnostics Market, Japan, Revenue ($m), 2014-2021 156
9.4.1 Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2007-2014 158
9.4.2 Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2014-2021 160
9.5 Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), 2013-2014 162
9.6 Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), 2014 163
10 Microbiology Culture Market, Japan 165
10.1 Microbiology Culture Market, Japan, Revenue Mix ($m), 2014 165
10.2 Microbiology Culture Market, Japan, Segment Contribution (%), 2014 166
10.3 Microbiology Culture Market, Japan, Revenue ($m), 2007-2014 168
10.4 Microbiology Culture Market, Japan, Revenue ($m), 2014-2021 170
10.4.1 Microbiology Analyzers Market, Japan, Revenue ($m), by Segment, 2007-2014 172
10.4.2 Microbiology Analyzers Market, Japan, Revenue ($m), by Segment, 2014-2021 174
10.5 Microbiology Culture Market, Japan, Distribution Share by Revenue ($m), 2013-2014 176
10.6 Microbiology Culture Market, Japan, Company Share by Revenue ($m), 2014 177
11 Overview of Key Companies in Japan, In Vitro Diagnostics Market 179
11.1 Siemens Healthcare 179
11.1.1 Company Overview 179
11.2 F. Hoffmann-La Roche Ltd. 179
11.2.1 Company Overview 179
11.3 Becton, Dickinson and Company 179
11.3.1 Company Overview 179
11.4 Danaher Corporation 180
11.4.1 Company Overview 180
11.5 Abbott Laboratories 180
11.5.1 Company Overview 180
11.6 Sysmex Corporation 180
11.6.1 Company Overview 180
11.7 bioMerieux S.A. 180
11.7.1 Company Overview 180
11.8 Thermo Fisher Scientific Inc. 181
11.8.1 Company Overview 181
11.9 Bio-Rad Laboratories, Inc. 181
11.9.1 Company Overview 181
11.10 Nihon Kohden Corporation 181
11.10.1 Company Overview 181
11.11 Eiken Chemical Co.,Ltd. 182
11.11.1 Company Overview 182
11.12 Ortho-Clinical Diagnostics Inc. 182
11.12.1 Company Overview 182
11.13 Alere Inc. 182
11.13.1 Company Overview 182
12 In Vitro Diagnostics Market Pipeline Products 183
13 Financial Deals Landscape 189
13.1 Acquisition 189
13.1.1 JPMorgan Chase to Acquire 5% Stake in Olympus from Sony for USD390 million 189
13.1.2 Sosei to Acquire Stake in Jitsubo for USDUSD1.8 Million 191
13.2 Equity Offerings 192
13.2.1 Jitsubo to Raise USD1.7 Million in Private Placement 192
13.3 Partnerships 193
13.3.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 193
13.3.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 194
13.3.3 OriGene Technologies Enters into Licensing Agreement with Diadexus 195
13.3.4 MdxHealth Enters into Licensing Agreement with Erasmus MC 196
13.3.5 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 197
13.3.6 SomaLogic Extends Research Agreement with Otsuka Pharma 198
13.3.7 Sigma-Aldrich Enters into Distribution Agreement with LGC 199
13.3.8 OvaGene Oncology Enters into Agreement with Etta Healthcare 200
13.3.9 InTouch Health Enters into Agreement with iSchemaView 201
13.3.10 Qiagen Enters into Agreement with Hitachi High-Technologies 202
13.3.11 Sysmex Enters into Co-Development Agreement with LabCorp 203
13.3.12 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 204
13.3.13 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 205
13.3.14 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 206
13.3.15 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 207
13.3.16 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 208
13.3.17 AngioDynamics Enters into Licensing Agreement with EmboMedics 209
13.3.18 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 210
13.3.19 Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 211
13.3.20 Biocartis Enters into Licensing and Development Agreement with Microbiome 212
13.3.21 CBScientific Enters into Distribution Agreement with UTest 213
13.3.22 GeneThera Enters into Co-Development Agreement with Hudson Robotics 214
13.3.23 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 215
13.3.24 Genomic Vision Extends Agreement with Quest Diagnostics 216
13.3.25 Dako Enters into Development Agreement with ONO PHARMA for Opdivo 217
13.3.26 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 218
13.3.27 BioMerieux Enters into Licensing Agreement with Astute Medical 219
13.3.28 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 220
13.3.29 NoemaLife Enters into Distribution Agreement with Horiba Medical 221
13.3.30 Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 222
13.3.31 Qiagen Enters into Co-Development Agreement with Astellas Pharma 223
13.3.32 Clinical Genomics Enters into Licensing Agreement with CSIRO 224
14 Recent Developments 225
14.1 Corporate Communications 225
14.1.1 Sep 15, 2015: Jamie McGarvey joins Astellas Pharma Corporate Affairs Team 225
14.1.2 Aug 20, 2015: Astellas Announces Changes in Personnel and Sales and Marketing Structure in Japan 225
14.1.3 Jun 15, 2015: Mr. Gary Huff Joins Baylor Miraca Genetics Laboratories as Chief Executive Officer 226
14.1.4 Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality 226
14.1.5 Apr 14, 2015: Nihon Kohden Names Dr. Wilson Constantine CEO of North America 227
14.1.6 Apr 06, 2015: Ono Pharmaceutical: Announcement on Candidates of Members of the Board of Directors, Corporate Auditors and Corporate Officers 228
14.1.7 Mar 06, 2015: Otsuka Pharmaceutical Appoints Board Members, Statutory Auditors 230
14.1.8 Feb 12, 2015: Notice of Change of Representative Director of Otsuka Pharmaceutical 231
14.1.9 Nov 12, 2014: Popular Science Recognizes Convergent Dental’s Solea CO2 Laser with Best of What’s New Award 231
14.2 Financial Announcements 232
14.2.1 Aug 03, 2015: Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2016 232
14.2.2 Jul 31, 2015: Tokuyama Announces Consolidated Results For Q1 FY2015 234
14.2.3 Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016 237
14.2.4 Jun 05, 2015: InVivo Therapeutics Announces Enrollment of Third Patient in Pilot Spinal Cord Injury Trial 238
14.2.5 Jun 04, 2015: Guided Therapeutics Awarded Multiple Tenders for LuViva Advanced Cervical Scan Systems from Governments in Bangladesh 239
14.2.6 Jun 04, 2015: Philips debuts Alice NightOne at-home sleep disorder diagnostic system 240
14.2.7 Jun 04, 2015: FDA Clears NovaBay Pharmaceuticals’ New High-Tech Device, intelli-Case, for Safely Disinfecting Contact Lenses with Hydrogen Peroxide 240
14.2.8 Jun 04, 2015: Roche receives FDA clearance for the cobas Cdiff Test to detect Clostridium difficile 242
14.2.9 May 15, 2015: Data Shows Improved Outcomes for Patients With St. Jude Medical Quadripolar CRT-P System 242
14.2.10 May 11, 2015: Nihon Kohden Consolidated Financial Results For The Fiscal Year Ended March 31, 2015 244
14.2.11 May 11, 2015: Shionogi Reports Net Sales Of JPY274 Billion In Fiscal 2015 248
14.2.12 May 01, 2015: Miraca Reports Revenue Of JPY204.7 Billion In Fiscal 2015 248
14.2.13 Apr 16, 2015: Alliqua Biomedical Receives Coverage From Medicare Administrative Contractor For Biovance 248
14.2.14 Apr 16, 2015: Pericoach Clinical Trial Recruitment Commences 249
14.2.15 Apr 16, 2015: Invibio: Meditech Spine uses PEEK-OPTIMA HA Enhanced from Invibio for next generation of cervical intervertebral fusion devices 252
14.2.16 Feb 12, 2015: Miraca Reports Revenue Of JPY154.1 Billion for Nine Months Ended December 31, 2014 253
14.2.17 Feb 04, 2015: Suzuken Reports Revenue Of JPY1.48 Trillion For Nine Months Ended December 31, 2014 253
14.2.18 Feb 03, 2015: Nihon Reports Revenue Of JPY108.3 Billion For Nine Months Ended December 31, 2014 255
14.2.19 Feb 02, 2015: Shionogi Reports Net Sales Of JPY200.3 Billion For The Nine Months Ended December 31, 2014 255
14.2.20 Nov 12, 2014: Mundipharma Announces Plans for Rapid Brand Expansion of BETAplast in South East Asia 256
14.2.21 Oct 31, 2014: Tosoh Reports Its First-Half Consolidated Results for Fiscal 2015 257
14.2.22 Oct 31, 2014: Nihon Kohden Announces FY2014 Second Quarter Consolidated Financial Results 259
14.2.23 Oct 31, 2014: Miraca Reports Revenue Of JPY102.2 Billion In H1 Fiscal 2015 260
14.2.24 Oct 29, 2014: SHIONOGI Announces Consolidated Financial Results For The Second Quarter Of Fiscal Year 2014 261
14.2.25 Oct 23, 2014: Eiken Chemical Reports Net Sales Of JPY15.8 Billion In H1 Fiscal 2015 261
14.3 Legal And Regulatory 261
14.3.1 Apr 16, 2015: PT Sysmex Indonesia achieves ISO 9001:2008 certification 261
14.3.2 Dec 18, 2014: EMC Center Designated As TUV Rheinland Japan Appointed Laboratory - Aiming to Become an Even More Reliable Testing Laboratory 262
14.3.3 Nov 06, 2014: Nihon Kohden Malaysia applies for a medical device manufacturer license 262
14.4 Other Significant Developments 263
14.4.1 Jun 29, 2015: LINK strengthens presence in Japan with new distribution agreements 263
14.4.2 May 02, 2015: ReproCELL Launches Worldwide Distribution Agreement with Nano3D Biosciences, Inc. 264
14.4.3 Mar 17, 2015: Quanterix Appoints SCRUM for Simoa Distribution in Japan 264
14.4.4 Feb 03, 2015: Fujifilm signs with the French technology research institute BIOASTER, a joint study contract for the evaluation of a rapid diagnostic system for the Ebola virus disease 265
14.5 Product News 265
14.5.1 Oct 01, 2015: Z Drift Compensator IX3-ZDC2 and Imaging Software cellSens v1.14 265
14.5.2 Aug 27, 2015: Sysmex Receives in-Vitro Diagnostic Approval for Manufacturing and Sales of Three Platelet Aggregation Agonist Reagent Kits 266
14.5.3 Jul 22, 2015: ImmunID Key Technology Patents Covering ImmunTraCkeR and ImmunIG Granted in the United States, Europe, Canada and Japan 267
14.5.4 Jun 04, 2015: Announcement on Development and Sales Launch of Research Reagent"Human Soluble Form VAP-1 Measurement Kit" utilizing our Monoclonal Antibody 267
14.5.5 May 19, 2015: S-BIO Launching BlotGlyco O-Glycan Sample Preparation Kit in U.S., Japan 268
14.5.6 Apr 28, 2015: Singulex Key Patent Granted in Japan for Detecting or Monitoring Cardiovascular Disease Using Proprietary Biomarkers 269
14.5.7 Mar 23, 2015: 2-Deoxyglucose Uptake Measurement Kit 269
14.5.8 Mar 18, 2015: Pacific Edge Adds To Its Growing List Of Issued Patents 270
14.5.9 Dec 25, 2014: Sysmex Launches the New Automated Hematology Analyzer XN-L series - a Compact Model in the XN Family 270
14.6 Strategy And Business Planning 271
14.6.1 Jul 07, 2015: Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy 271
14.6.2 Mar 31, 2015: Completion of Construction for New Research Building in Fuji Research Park 272
14.6.3 Feb 16, 2015: Shimadzu Goes Direct in Malaysia 272
14.6.4 Jan 27, 2015: Otsuka Australia Pharmaceutical Opens in Australia 274
14.6.5 Nov 26, 2014: Sysmex Establishes New Subsidiary in Australia - Aiming to Further Increase the Company's Presence in the Asia-Pacific Region 274
14.6.6 Nov 21, 2014: Nutrition & Sante Inaugurates New Factory Expanding Production Base of the French Leader in Functional and Dietetic Foods 275
14.6.7 Nov 14, 2014: Otsuka Group Establishes New Company in Order to Strengthen Presence in Vending Machine Market 275
14.6.8 Oct 30, 2014: Kyowa Hakko Kirin Announces Completion of Construction for Drug Product Manufacturing Facility in the Takasaki Plant 275
15 Appendix 277
15.1 Research Methodology 278
15.1.1 Coverage 278
15.1.2 Secondary Research 278
15.1.3 Primary Research 278
15.1.4 Company Share Analysis 279
15.1.5 Distribution Share Analysis 279
15.2 GlobalData Consulting 279
15.3 Contact Us 279
15.4 Disclaimer 280

List Of Tables
1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Japan, Revenue ($m), USD Constant, 2007-2021 31
Table 2: In Vitro Diagnostics Market, Japan, Category Contribution by Revenue ($m), 2014 33
Table 3: In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), USD Constant, 2007-2021 35
Table 4: In Vitro Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 5: In Vitro Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 6: In Vitro Diagnostics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 41
Table 7: Clinical Chemistry Market, Japan, Segment Contribution (%), 2014 44
Table 8: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 9: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 10: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 11: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 12: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 13: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 14: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 15: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 16: Clinical Chemistry Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 61
Table 17: Clinical Chemistry Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 63
Table 18: Genetic Testing Market, Japan, Segment Contribution (%), 2014 65
Table 19: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 67
Table 20: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Table 21: Genetic Testing Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 70
Table 22: Genetic Testing Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 72
Table 23: Haematology Market, Japan, Segment Contribution (%), 2014 75
Table 24: Haematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 77
Table 25: Haematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 79
Table 26: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 27: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 28: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 29: Haemostasis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 30: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 31: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 32: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 33: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 34: Haemostasis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 35: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 36: Haematology Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 100
Table 37: Haematology Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 102
Table 38: Histology And Cytology Market, Japan, Segment Contribution (%), 2014 105
Table 39: Histology And Cytology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 107
Table 40: Histology And Cytology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 109
Table 41: Histology And Cytology Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 110
Table 42: Histology And Cytology Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 112
Table 43: Immuno Chemistry Market, Japan, Segment Contribution (%), 2014 115
Table 44: Immuno Chemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 117
Table 45: Immuno Chemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 119
Table 46: Anemia Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 47: Disease Specific Immunochemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 123
Table 48: Endocrinology Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 49: IgE Allergy Blood Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 50: Immunochemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 51: Immunochemistry Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 52: Vitamins Tests Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 133
Table 53: Anemia Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 54: Disease Specific Immunochemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Table 55: Endocrinology Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 56: IgE Allergy Blood Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 57: Immunochemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 58: Immunochemistry Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Table 59: Vitamins Tests Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 147
Table 60: Immuno Chemistry Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 148
Table 61: Immuno Chemistry Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 150
Table 62: Infectious Diagnostics Market, Japan, Segment Contribution (%), 2014 153
Table 63: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 155
Table 64: Infectious Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Table 65: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 159
Table 66: Infectious Diagnostics Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 161
Table 67: Infectious Diagnostics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 162
Table 68: Infectious Diagnostics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 164
Table 69: Microbiology Culture Market, Japan, Segment Contribution (%), 2014 167
Table 70: Microbiology Culture Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 169
Table 71: Microbiology Culture Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Table 72: Microbiology Analyzers Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 173
Table 73: Microbiology Analyzers Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 175
Table 74: Microbiology Culture Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 176
Table 75: Microbiology Culture Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 178
Table 76: In Vitro Diagnostics Market Pipeline Products 183
Table 77: JPMorgan Chase to Acquire 5% Stake in Olympus from Sony for USD390 million 189
Table 78: Sosei to Acquire Stake in Jitsubo for USDUSD1.8 Million 191
Table 79: Jitsubo to Raise USD1.7 Million in Private Placement 192
Table 80: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 193
Table 81: Seegene Enters into Co-Development Agreement with BD Life Sciences 194
Table 82: OriGene Technologies Enters into Licensing Agreement with Diadexus 195
Table 83: MdxHealth Enters into Licensing Agreement with Erasmus MC 196
Table 84: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 197
Table 85: SomaLogic Extends Research Agreement with Otsuka Pharma 198
Table 86: Sigma-Aldrich Enters into Distribution Agreement with LGC 199
Table 87: OvaGene Oncology Enters into Agreement with Etta Healthcare 200
Table 88: InTouch Health Enters into Agreement with iSchemaView 201
Table 89: Qiagen Enters into Agreement with Hitachi High-Technologies 202
Table 90: Sysmex Enters into Co-Development Agreement with LabCorp 203
Table 91: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 204
Table 92: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 205
Table 93: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 206
Table 94: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 207
Table 95: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 208
Table 96: AngioDynamics Enters into Licensing Agreement with EmboMedics 209
Table 97: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 210
Table 98: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 211
Table 99: Biocartis Enters into Licensing and Development Agreement with Microbiome 212
Table 100: CBScientific Enters into Distribution Agreement with UTest 213
Table 101: GeneThera Enters into Co-Development Agreement with Hudson Robotics 214
Table 102: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 215
Table 103: Genomic Vision Extends Agreement with Quest Diagnostics 216
Table 104: Dako Enters into Development Agreement with ONO PHARMA for Opdivo 217
Table 105: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 218
Table 106: BioMerieux Enters into Licensing Agreement with Astute Medical 219
Table 107: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 220
Table 108: NoemaLife Enters into Distribution Agreement with Horiba Medical 221
Table 109: Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 222
Table 110: Qiagen Enters into Co-Development Agreement with Astellas Pharma 223
Table 111: Clinical Genomics Enters into Licensing Agreement with CSIRO 224

List Of Figures
1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Japan, Revenue ($m), USD Constant, 2007-2021 30
Figure 2: In Vitro Diagnostics Market, Japan, Revenue Mix ($m), 2014 32
Figure 3: In Vitro Diagnostics Market, Japan, Category Contribution (%), 2014 33
Figure 4: In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Figure 5: In Vitro Diagnostics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 6: In Vitro Diagnostics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 7: In Vitro Diagnostics Market, Japan, Company Share (%) 2014 40
Figure 8: Clinical Chemistry Market, Japan, Revenue Mix ($m), 2014 42
Figure 9: Clinical Chemistry Market, Japan, Segment Contribution (%), 2014 43
Figure 10: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 11: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 12: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 13: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 14: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 15: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 16: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 17: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 18: Clinical Chemistry Market, Japan, Company Share (%) 2014 62
Figure 19: Genetic Testing Market, Japan, Revenue Mix ($m), 2014 64
Figure 20: Genetic Testing Market, Japan, Segment Contribution (%), 2014 65
Figure 21: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 66
Figure 22: Genetic Testing Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Figure 23: Genetic Testing Market, Japan, Company Share (%) 2014 71
Figure 24: Haematology Market, Japan, Revenue Mix ($m), 2014 73
Figure 25: Haematology Market, Japan, Segment Contribution (%), 2014 74
Figure 26: Haematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 76
Figure 27: Haematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Figure 28: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 29: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 30: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 31: Haemostasis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 32: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 33: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Figure 34: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 35: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 36: Haemostasis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 37: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Figure 38: Haematology Market, Japan, Company Share (%) 2014 101
Figure 39: Histology And Cytology Market, Japan, Revenue Mix ($m), 2014 103
Figure 40: Histology And Cytology Market, Japan, Segment Contribution (%), 2014 104
Figure 41: Histology And Cytology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 106
Figure 42: Histology And Cytology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Figure 43: Histology And Cytology Market, Japan, Company Share (%) 2014 111
Figure 44: Immuno Chemistry Market, Japan, Revenue Mix ($m), 2014 113
Figure 45: Immuno Chemistry Market, Japan, Segment Contribution (%), 2014 114
Figure 46: Immuno Chemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 116
Figure 47: Immuno Chemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.